The Philippines is considered the 10th most attractive pharmaceutical market in the Asia-Pacific region and the third-largest in the ASEAN group.
The country’s pharmaceutical industry is projected to grow by 4.5 per cent annually over the next five years reaching over PHP 209 billion in 2020 from PHP167 billion in 2014.
Government budget for health is significantly increasing:
29% growth from US$1.57 billion in 2014 to US$2.02 billion in 2018
The growing population and economic development in the Philippines point to a pharmaceutical market of 110 million population.
Healthcare spending vs GDP is growing from 2.79% in 2002 to 4.7% in 2017 (US$12.6 billion).
Pharma14 brings you national tender information information as well as wide coverage on ex-factory, wholesale and retail pricing.
Sample Philippines data: Trastuzumab. Ex-factory tender pricing.
60 Medinat Hayehudim St.
Entrance C. Third floor.